Research ExplorerPublicationsThe Coronary Artery Disease and Renal Failure (CAD-REF) regi...

The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims.

Standard

The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims. / Brand, Eva; Pavenstädt, Hermann; Schmieder, Roland E; Engelbertz, Christiane; Fobker, Manfred; Pinnschmidt, Hans; Wegscheider, Karl; Breithardt, Günter; Reinecke, Holger.

In: AM HEART J, Vol. 166, No. 3, 3, 2013, p. 441-449.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Brand, E, Pavenstädt, H, Schmieder, RE, Engelbertz, C, Fobker, M, Pinnschmidt, H, Wegscheider, K, Breithardt, G & Reinecke, H 2013, 'The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims.', AM HEART J, vol. 166, no. 3, 3, pp. 441-449. <http://www.ncbi.nlm.nih.gov/pubmed/24016493?dopt=Citation>

APA

Brand, E., Pavenstädt, H., Schmieder, R. E., Engelbertz, C., Fobker, M., Pinnschmidt, H., Wegscheider, K., Breithardt, G., & Reinecke, H. (2013). The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims. AM HEART J, 166(3), 441-449. [3]. http://www.ncbi.nlm.nih.gov/pubmed/24016493?dopt=Citation

Vancouver

Brand E, Pavenstädt H, Schmieder RE, Engelbertz C, Fobker M, Pinnschmidt H et al. The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims. AM HEART J. 2013;166(3):441-449. 3.

Bibtex

@article{64da6957f7a640b3b30ef22b2ae63b0e,
title = "The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims.",
abstract = "During the past 10 years, chronic kidney disease (CKD) has been recognized as a major global health problem. Factors leading to decreased renal function are closely related to cardiovascular disease and vice versa. Cardiovascular morbidity and mortality are substantially increased in patients with CKD, even in those with only mild or moderate renal impairment. A better understanding of pathogenesis, risk factors, and genetic conditions is strongly required for more specific treatment strategies in CKD because until now, knowledge is very limited.",
author = "Eva Brand and Hermann Pavenst{\"a}dt and Schmieder, {Roland E} and Christiane Engelbertz and Manfred Fobker and Hans Pinnschmidt and Karl Wegscheider and G{\"u}nter Breithardt and Holger Reinecke",
year = "2013",
language = "English",
volume = "166",
pages = "441--449",
journal = "AM HEART J",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - The Coronary Artery Disease and Renal Failure (CAD-REF) registry: Trial design, methods, and aims.

AU - Brand, Eva

AU - Pavenstädt, Hermann

AU - Schmieder, Roland E

AU - Engelbertz, Christiane

AU - Fobker, Manfred

AU - Pinnschmidt, Hans

AU - Wegscheider, Karl

AU - Breithardt, Günter

AU - Reinecke, Holger

PY - 2013

Y1 - 2013

N2 - During the past 10 years, chronic kidney disease (CKD) has been recognized as a major global health problem. Factors leading to decreased renal function are closely related to cardiovascular disease and vice versa. Cardiovascular morbidity and mortality are substantially increased in patients with CKD, even in those with only mild or moderate renal impairment. A better understanding of pathogenesis, risk factors, and genetic conditions is strongly required for more specific treatment strategies in CKD because until now, knowledge is very limited.

AB - During the past 10 years, chronic kidney disease (CKD) has been recognized as a major global health problem. Factors leading to decreased renal function are closely related to cardiovascular disease and vice versa. Cardiovascular morbidity and mortality are substantially increased in patients with CKD, even in those with only mild or moderate renal impairment. A better understanding of pathogenesis, risk factors, and genetic conditions is strongly required for more specific treatment strategies in CKD because until now, knowledge is very limited.

M3 - SCORING: Journal article

VL - 166

SP - 441

EP - 449

JO - AM HEART J

JF - AM HEART J

SN - 0002-8703

IS - 3

M1 - 3

ER -